CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $333,000 | -13.7% | 3,100 | 0.0% | 0.02% | -12.0% |
| Q3 2016 | $386,000 | +17.0% | 3,100 | 0.0% | 0.02% | +13.6% |
| Q2 2016 | $330,000 | -7.0% | 3,100 | 0.0% | 0.02% | -12.0% |
| Q1 2016 | $355,000 | -19.7% | 3,100 | 0.0% | 0.02% | -30.6% |
| Q4 2015 | $442,000 | +59.0% | 3,100 | 0.0% | 0.04% | +56.5% |
| Q3 2015 | $278,000 | -22.1% | 3,100 | 0.0% | 0.02% | -11.5% |
| Q2 2015 | $357,000 | +20.6% | 3,100 | 0.0% | 0.03% | +18.2% |
| Q1 2015 | $296,000 | +42.3% | 3,100 | 0.0% | 0.02% | +37.5% |
| Q4 2014 | $208,000 | – | 3,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |